CCR5 Ligands in HIV Vaccines

Figure 3. Production of chemokines and [H3]-Thymidine uptake following antigen stimulation at day 3 (A panels) and day 6 (B panels) ifrom cells of subjects vaccinated more than 10 years prior to blood donation. Al and Bl: raw values. A2 and B2: stimulation indices. N=4. (B1) w 9000 8000 7000 6000 5000 4000 3000 2000 1000 Control TTx 3 ug/ml TTx 10 TTx 20 Candida 10 TTx 3 ug/ml TTx 10 ug/ml TTx 20 ug/mI Candida 10 PHA 5 ng/ml ug/ml ug/ml ug/ml ug/ml Figure 4. Production of MDC and 1309 following antigen stimulation at days 3;6 and 9. N=4. MDC and 1309 release from antigen activated cells 0 25000 SMDC 20000 *1309 15000 1 1~V VV c10000 I t I I IJ 500o n -Yvvv (1 1. 1 1 1,,, Day 3 Day 6 Day9d i

/ 23

Actions

file_download Download Options Download this page PDF - Pages #1-23 Image - Page 21 Plain Text - Page 21

About this Item

Title
CCR5 Ligands in HIV Vaccines
Author
Garzino-Demo, Alfredo
Canvas
Page 21
Publication
undated
Subject terms
proposals
Item type:
proposals

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0230.031
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0230.031/22

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0230.031

Cite this Item

Full citation
"CCR5 Ligands in HIV Vaccines." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0230.031. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.